{"text": "Taken together, our study indicate variable expression and clinical role of B7-family ligands in SCLC with predominant expression of the candidate target B7-H3 and the presence of a limited cytotoxic anti-tumor immune response. These results support the evaluation of B7-H3 blockers and/or pro-inflammatory therapies in SCLC.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 76, "end": 93}}, {"id": "T2", "obj": "disease", "span": {"begin": 97, "end": 101}}, {"id": "T3", "obj": "gene", "span": {"begin": 154, "end": 159}}]}
